Skip to content Skip to footer
team-Bianchi

M.D.

Dr.ssa. Francesca Bianchi

Dr Francesca Bianci obtained her medical degree in 2009 medical degree at Alma Mater Studiorum Bologna University (Italy), and the Clinical Neurophysiology certification at Vita Salute University San Raffaele of Milan (Italy) in 2015.

Italy

Biography

Dr Francesca Bianci obtained her medical degree in 2009 medical degree at Alma Mater Studiorum Bologna University (Italy), and the Clinical Neurophysiology certification at Vita Salute University San Raffaele of Milan (Italy) in 2015. Since 2015 Dr Bianchi works as a clinical neurophysiologist at San Raffaele Scientific Institute of Milan specifically involved in electromyography and intraoperative neurophysiological monitoring.

She has more than ten years of experience in botulinum toxin treatment of movement disorders (i.e. spasticity and dystonia) as well as of pain syndromes. In 2018 she completed the advanced course of joint-skeletal muscle ultrasound at the Ultrasound Advanced School of Bologna (SIUMB), with the achievement of skills in US-guided interventional procedures and peripheral nervous system US.

Furthermore she has several years of experience in the diagnosis and treatment of pelvic floor disorders, directly involved in the pelvic unit multidisciplinary team of San Raffaele Scientific Institute, She has been the coordinator of the study group ‘Neurophysiology of the pelvic floor’ of the Italian Society of Clinical Neurophysiology (SINC) since 2018. In addition she has been involved in national and international clinical trials focused on spasticity, peripheral neuropathies and intraoperative neurophysiological monitoring since 2010.

She is the author of articles published in peer-review journals, chapters of scientific books and abstracts and has been invited as a speaker for national and international conferences on the topic of pelvic floor neurophysiology, pelvic pain syndromes, botulinum toxin treatment and intraoperative neurophysiological monitoring.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.